Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.

Matthias Ocker; Christian Reinhard Mayr; Tobias Kiesslich; Sebastian Stintzing; Daniel Neureiter

doi:10.3390/cancers13071558

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.

Matthias Ocker
, Christian Reinhard Mayr (Co-author)
, Tobias Kiesslich (Co-author)
, Sebastian Stintzing
, Daniel Neureiter^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

11 Citations (Web of Science)

Original language	English
Journal	Cancers
Volume	13
Issue number	7
DOIs	https://doi.org/10.3390/cancers13071558
Publication status	Published - 2021

Access to Document

10.3390/cancers13071558

Cite this

@article{f0b066b5c28b4a4082d048741cfaf6ad,

title = "Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.",

author = "Matthias Ocker and Mayr, \{Christian Reinhard\} and Tobias Kiesslich and Sebastian Stintzing and Daniel Neureiter",

note = "Kiesslich; Mayr: Institute of Physiology and Pathophysiology, Paracelsus Medical University, 5020 Salzburg, Austria; Department of Internal Medicine I, Paracelsus Medical University, University Hospital Salzburg (SALK), 5020 Salzburg, Austria; Neureiter: Paracelsus Med Univ, Univ Hosp Salzburg SALK, Inst Pathol, A-5020 Salzburg, Austria; ",

year = "2021",

doi = "10.3390/cancers13071558",

language = "English",

volume = "13",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "7",

}

TY - JOUR

T1 - Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.

AU - Ocker, Matthias

AU - Mayr, Christian Reinhard

AU - Kiesslich, Tobias

AU - Stintzing, Sebastian

AU - Neureiter, Daniel

N1 - Kiesslich; Mayr: Institute of Physiology and Pathophysiology, Paracelsus Medical University, 5020 Salzburg, Austria; Department of Internal Medicine I, Paracelsus Medical University, University Hospital Salzburg (SALK), 5020 Salzburg, Austria; Neureiter: Paracelsus Med Univ, Univ Hosp Salzburg SALK, Inst Pathol, A-5020 Salzburg, Austria;

PY - 2021

Y1 - 2021

U2 - 10.3390/cancers13071558

DO - 10.3390/cancers13071558

M3 - Review article

C2 - 33805268

SN - 2072-6694

VL - 13

JO - Cancers

JF - Cancers

IS - 7

ER -